This educational activity is specifically designed for gastroenterologists, hospitalists, internal medicine specialists, and other healthcare professionals (physicians in training, nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD.
After completing this activity, participants should be able to:
- Describe the current understanding of IBD pathophysiology with respect to inflammatory signaling pathways and potential therapeutic targets
- Integrate clinical evidence, recent real-world data, current guidelines, and patient preferences into individualized treatment plans for IBD patients
- Assess the mechanism of action and therapeutic potential of evolving treatments in IBD
- Interpret clinical data for integration into the management of special patient populations in IBD
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Requirements for Credit
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 60 days of the conference will receive immediate documentation of credit. For questions regarding this activity, please email firstname.lastname@example.org.
Credit Designation Statements
HMP Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™.
HMP Education designates this enduring activity for a maximum of 9.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants are not eligible to receive credit for any part of this enduring material if credit was claimed as part of the internet live event.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 7.0 AAPA Category 1 credits.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 9.25 AAPA Category 1 credits.
Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. Participants are not eligible to receive credit for any part of this enduring material if credit was claimed as part of the internet live event.
This continuing nursing education live activity awards 7.0 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for 7.0 contact hours.
This continuing nursing education enduring activity awards 9.25 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for 9.25 contact hours.
This live, knowledge-based activity (Universal Activity Number - JA0006201-0000-23-015-L01-P) has been approved for a maximum of 7.0 contact hours (.70 CEUs).
This enduring, knowledge-based activity (Universal Activity Number - JA0006201-0000-23-024-H01-P) has been approved for a maximum of 9.25 contact hours (.925 CEUs).
ACPE Credit Policy
The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity. HMP Education is not able to report your claimed credit after this 60-day period. Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Participants are not eligible to receive credit for any part of this enduring material if credit was claimed as part of the internet live event.
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call (770) 751- 7332 / (609) 371-1137.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609.371.1137, by email at email@example.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.
Non-Accredited Innovation Theaters
These are promotional programs and no CE credits are offered. All attendees, please be advised that information—eg, your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
Advances in Inflammatory Bowel Diseases is supported in part by educational grants from AbbVie, Bristol Myers Squibb, Fresenius Kabi, and Takeda Pharmaceuticals U.S.A. Please see agenda for individual session support.